Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Integrin-linked kinase is crucial for normal skin healing.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Inhibiting PLA2 enzymes may help treat inflammatory skin diseases like psoriasis and dermatitis.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

COX-2 and Bcl-2 proteins are involved in Lichen Planus.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Retinol may affect immune responses in people with frequent skin boils.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

p120-catenin helps control skin inflammation by regulating cadherin levels.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

PCOS is linked to low-grade chronic inflammation.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.